Cognition Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina.
The share price is rising and gonna continue this trend today.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price today.
So I opened a long position from $12.87; stop-loss — $11.78; take-profit — 16.14/MOC price.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision. Always do your own analysis before making deals. When you use any materials, do not rely on blind trust. You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Great alert and analysis, thanks.
Question: what is your thinkikng process behind your stop-loss point? I see the open price at 12.10, what am I missing here?
Question: what is your thinkikng process behind your stop-loss point? I see the open price at 12.10, what am I missing here?